Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Bioceltix is a Polish biotechnology company developing veterinary medicines based on mesenchymal stem cells. Its products target mainly inflammatory and orthopaedic conditions in dogs and horses.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Bioceltix is scheduled to report its next quarterly earnings on 11/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Bioceltix last reported quarterly earnings on 9/23/2026 (Q2 2026).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.